Fresenius Medical Care AG & Co. KGAA (FME) Given a €95.60 Price Target by Berenberg Bank Analysts

Fresenius Medical Care AG & Co. KGAA (ETR:FME) has been assigned a €95.60 ($113.81) price objective by investment analysts at Berenberg Bank in a note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price target would indicate a potential upside of 11.09% from the company’s current price.

A number of other brokerages have also recently weighed in on FME. J P Morgan Chase & Co set a €95.60 ($113.81) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Tuesday. S&P Global set a €95.00 ($113.10) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Monday, November 6th. Credit Suisse Group set a €92.00 ($109.52) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Monday, November 6th. HSBC set a €85.00 ($101.19) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a “neutral” rating in a research note on Wednesday, November 22nd. Finally, Goldman Sachs Group set a €97.00 ($115.48) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Monday, November 6th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of €89.06 ($106.03).

Shares of Fresenius Medical Care AG & Co. KGAA (FME) traded down €0.04 ($0.05) on Wednesday, hitting €86.06 ($102.45). 272,790 shares of the stock were exchanged, compared to its average volume of 517,453. Fresenius Medical Care AG & Co. KGAA has a fifty-two week low of €71.49 ($85.11) and a fifty-two week high of €89.22 ($106.21).

COPYRIGHT VIOLATION WARNING: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2017/12/06/fresenius-medical-care-ag-95-60-price-target-by-berenberg-bank-analysts.html.

Fresenius Medical Care AG & Co. KGAA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. KGAA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGAA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit